Panagora Asset Management Inc Cyma Bay Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$3.94 - $4.92 $3,782 - $4,723	-960 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$5.73 - $9.03 $5,500 - $8,668	960 New	960 $6,000
Q2 2020 Aug 12, 2020	SELL	$1.41 - $4.25 $31,340 - $94,464	-22,227 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$1.33 - $5.93 $29,561 - $131,806	22,227 New	22,227 $44,000
Q2 2018 Aug 14, 2018	SELL	$10.66 - $14.38 $43,535 - $58,727	-4,084 Closed	0 $0

Q1 2018 May 15, 2018	BUY	$9.0 - $15.16 $36,756 - $61,913	4,084 New	4,084 $53,000

1.88M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.